Kalantar-Zadeh Kamyar, Kovesdy Csaba P, Streja Elani, Rhee Connie M, Soohoo Melissa, Chen Joline L T, Molnar Miklos Z, Obi Yoshitsugu, Gillen Daniel, Nguyen Danh V, Norris Keith C, Sim John J, Jacobsen Steve S
Harold Simmons Center for Kidney Disease Research and Epidemiology, Division of Nephrology and Hypertension, University of California Irvine Medical Center, Orange, CA, USA.
VA Long Beach Healthcare System, Long Beach, CA, USA.
Nephrol Dial Transplant. 2017 Apr 1;32(suppl_2):ii91-ii98. doi: 10.1093/ndt/gfw357.
In patients with advanced (estimated glomerular filtration rate <25 mL/min/1.73 m2) non-dialysis-dependent chronic kidney disease (CKD) the optimal transition of care to renal replacement therapy (RRT), i.e. dialysis or transplantation, is not known. Mortality and hospitalization risk are extremely high upon transition and in the first months following the transition to dialysis. Major knowledge gaps persist pertaining to differential or individualized transitions across different demographics and clinical measures during the 'prelude' period prior to the transition, particularly in several key areas: (i) the best timing for RRT transition; (ii) the optimal RRT type (dialysis versus transplant), and in the case of dialysis, the best modality (hemodialysis versus peritoneal dialysis), format (in-center versus home), frequency (infrequent versus thrice-weekly versus more frequent) and vascular access preparation; (iii) the post-RRT impact of pre-RRT prelude conditions and events such as blood pressure and glycemic control, acute kidney injury episodes, and management of CKD-specific conditions such as anemia and mineral disorders; and (iv) the impact of the above prelude conditions on end-of-life care and RRT decision-making versus conservative management of CKD. Given the enormous changes occurring in the global CKD healthcare landscape, as well as the high costs of transitioning to dialysis therapy with persistently poor outcomes, there is an urgent need to answer these important questions. This review describes the key concepts and questions related to the emerging field of 'Transition of Care in CKD', systematically defines six main categories of CKD transition, and reviews approaches to data linkage and novel prelude analyses along with clinical applications of these studies.
在晚期(估计肾小球滤过率<25 mL/分钟/1.73 m²)非透析依赖型慢性肾脏病(CKD)患者中,向肾脏替代治疗(RRT)即透析或移植的最佳护理过渡尚不清楚。在过渡到透析时以及过渡后的头几个月,死亡率和住院风险极高。在过渡前的“前奏”期,在不同人口统计学和临床指标的差异或个体化过渡方面仍存在重大知识空白,特别是在几个关键领域:(i)RRT过渡的最佳时机;(ii)最佳的RRT类型(透析与移植),以及在透析情况下,最佳模式(血液透析与腹膜透析)、形式(中心透析与家庭透析)、频率(不频繁与每周三次与更频繁)和血管通路准备;(iii)RRT前的前奏状况和事件(如血压和血糖控制、急性肾损伤发作以及CKD特异性状况如贫血和矿物质紊乱的管理)对RRT后的影响;以及(iv)上述前奏状况对临终护理和RRT决策与CKD保守管理的影响。鉴于全球CKD医疗格局发生的巨大变化,以及过渡到透析治疗成本高昂且结局持续不佳,迫切需要回答这些重要问题。本综述描述了与“CKD护理过渡”这一新兴领域相关的关键概念和问题,系统地定义了CKD过渡的六个主要类别,并综述了数据关联方法和新颖的前奏分析以及这些研究的临床应用。